IMARC Group, a leading global market research and management consulting firm, has published its latest market intelligence report on the Saudi Arabia hemodialysis market size reached USD 877.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,247.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.99% during 2026-2034, driven by the rising prevalence of chronic kidney disease, sustained government investment in healthcare infrastructure, increasing private sector participation, expanded health insurance coverage, and growing adoption of digital health technologies that support patient-centered renal care.
The market is experiencing steady growth momentum as chronic conditions such as diabetes and hypertension, both highly prevalent across the Kingdom, continue to drive rising cases of chronic kidney disease and end-stage renal failure requiring long-term dialysis support. Saudi Arabia currently operates hundreds of hemodialysis centers equipped with thousands of dialysis machines nationwide, reflecting the scale of infrastructure required to meet growing patient volumes. Government-backed expansion of dialysis facilities, combined with rising private healthcare investment and public-private partnerships, is reinforcing treatment accessibility across urban and remote regions of the country.
How AI is Reshaping the Future of the Saudi Arabia Hemodialysis Market?
- AI-Enabled Remote Patient Monitoring: Technologies such as Baxter’s Claria platform with Sharesource enable healthcare providers to remotely monitor peritoneal and home dialysis patients, tracking adherence patterns and treatment data in real time, allowing clinicians to intervene earlier and reduce hospitalization risk among Saudi renal care patients.
- AI-Driven Predictive Analytics for Patient Outcomes: Hospitals and dialysis centers are increasingly using AI-based outcome-tracking systems and patient feedback platforms to continuously refine care protocols, enabling data-driven adjustments to treatment plans that improve clinical benchmarks across public and private dialysis networks.
- AI-Optimized Facility and Equipment Management: Dialysis providers are applying machine learning to scheduling, machine utilization, and consumables inventory across large-scale centers, helping reduce operational downtime and ensuring consistent treatment availability as patient volumes rise across the Northern, Central, Western, and Eastern regions of the Kingdom.
Grab a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-hemodialysis-market/requestsample
Saudi Arabia Hemodialysis Market Trends and Drivers
The rising incidence of chronic kidney disease remains the principal driver of hemodialysis demand in Saudi Arabia, with lifestyle-linked conditions such as diabetes and hypertension contributing significantly to the growing patient pool requiring renal replacement therapy. As the number of patients in need of dialysis services climbs, the government has responded with aggressive funding of healthcare infrastructure, expansion of dialysis facilities, and public awareness campaigns targeting early detection of kidney disease. Saudi Arabia has invested more than USD 64 Billion in broader healthcare infrastructure in recent years as part of Vision 2030, supporting the establishment of over 200 new dialysis facilities across both urban centers and remote areas of the Kingdom.
Public-private partnerships are playing an increasingly central role in expanding dialysis capacity. Makkah Health Cluster partnered with the Mutlaq bin Saleh Al-Hanaki National Foundation to build a 150-bed dialysis center at Al-Noor Hospital, an initiative aligned with Vision 2030’s goal of strengthening the non-profit sector’s contribution to health development. Global manufacturers are also deepening their Saudi footprint: Baxter and the Olayan Group operate a joint-venture manufacturing facility in the southern region of the Kingdom that currently serves more than 1,500 renal dialysis patients, producing peritoneal dialysis and IV solutions with plans to expand supply across the wider Middle East.
Home-based and peritoneal dialysis is gaining traction as the Ministry of Health works with the National Unified Procurement Company to coordinate home delivery programs for dialysis solutions, improving patient comfort while easing pressure on in-center capacity. Humanitarian and regional outreach programs are complementing domestic expansion, with initiatives delivering tens of tons of medical supplies, high-efficiency dialyzers, and advanced dialysis equipment to underserved renal care centers, reflecting the broader regional commitment to strengthening kidney care access. Meanwhile, international dialysis chains are entering the market directly, with dedicated dialysis center operators announcing plans to open Saudi facilities as part of their Gulf Cooperation Council expansion strategy, intensifying competition and widening treatment choice for patients across the Kingdom.
Saudi Arabia Hemodialysis Market Segmentation
The report has segmented the market into the following categories:
Breakup by Product Type:
- Hemodialysis Machines (In-Center and Home-Based)
- Hemodialysis Consumables (Dialyzers, Dialysate, Access Products, Others)
- Services
Hemodialysis consumables account for a substantial share of ongoing market revenue given the recurring nature of dialyzers, dialysate, and vascular access products required for each treatment session, while home-based hemodialysis machines are gaining momentum as patients and providers prioritize convenience and reduced center-based dependency.
Breakup by End User:
- Hospitals
- Independent Dialysis Centers
- Home Care Settings
Hospitals function as the primary treatment hubs, offering state-of-the-art facilities and specialist nephrology support, while independent dialysis centers are expanding rapidly to offer more convenient, community-based access for patients requiring recurring sessions closer to home.
Breakup by Region:
- Northern and Central Region
- Western Region
- Eastern Region
- Southern Region
The Northern and Central regions are witnessing significant demand growth due to rising chronic kidney disease cases and expanding urban populations, supported by substantial government spending on cutting-edge dialysis equipment, while the Western region benefits from a strong existing healthcare infrastructure base serving Makkah and surrounding areas.
Competitive Landscape
The report provides a comprehensive analysis of the competitive landscape in the Saudi Arabia hemodialysis market with detailed profiles of key players, including global renal care leaders such as Fresenius Medical Care, Baxter International, B. Braun Melsungen AG, DaVita Inc., and Nipro Medical Corporation, alongside regional dialysis network operators and healthcare providers expanding their presence through facility openings, joint ventures, and government partnerships across the Kingdom.
Recent News and Developments in Saudi Arabia Hemodialysis Market
- February 2025: NephroPlus, one of Asia’s largest dialysis networks, announced plans to open a dialysis center in Saudi Arabia by the end of the year, marking its fourth country of operation outside India and expanding its footprint across the Gulf Cooperation Council region.
- March 2025: Saudi Arabia’s Minister of Health met with representatives of Baxter Company Limited around World Kidney Day observances, discussing plans to strengthen peritoneal dialysis services and coordinate home delivery programs with the National Unified Procurement Company.
- 2025: KSrelief supported dialysis centers in the Marib and Harib Directorates by delivering approximately 30 tons of medical supplies and dialysis solutions, including high-efficiency dialyzers and advanced equipment, to strengthen regional renal care services.
- 2025: Makkah Health Cluster advanced its community partnership with the Mutlaq bin Saleh Al-Hanaki National Foundation to establish a 150-bed dialysis center at Al-Noor Hospital, reinforcing Vision 2030’s healthcare access goals.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201-971-6302
